Vol 62, No 3 (2005)
Other
Published online: 2005-12-12
Submitted: 2012-12-28
Get Citation

Atrial natriuretic peptide for monitoring cardiovascular system performance following pacemaker implantation

Janusz Sielski, Marianna Janion, Zenon Gawor
Kardiol Pol 2005;62(3):206-209.
Vol 62, No 3 (2005)
Other
Published online: 2005-12-12
Submitted: 2012-12-28

Abstract

Background: The effects of different modes of pacing on cardiac performance have been investigated in a few small studies, and the results are not conclusive.
Aim: To assess the effects of different modes of pacing on atrial natriuretic peptide (ANP) plasma concentration and left ventricular ejection fraction (LVEF).
Methods: The study group consisted of 55 subjects without symptomatic CHF. Forty patients were in sinus rhythm and had a-v block. Twenty of them, aged 71-90 years, mean 77.5±5.9 years, received VVI pacemaker, and the remaining 20 patients aged 49-81 years, mean 68.9±11.9 years, received DDD or VDD pacemakers. The control group consisted of 15 healthy volunteers aged 58-80 years, mean 72.6±2.8 years. Blood samples for α ANP concentration were taken before pacemaker implantation and 7 as well as 30 days after pacemaker implantation. In controls, a single α ANP measurement was performed. Transthoracic echocardiography was performed in all patients and controls at the same time-points as ANP assessment in order to calculate LVEF.
Results: Before pacemaker implantation, ANP plasma concentration was the highest in VVI patients and was significantly greater in patients than in controls. Following VVI pacemaker implantation, ANP level significantly decreased, both 7 and 30 days after implantation when compared with baseline values. Also following implantation of dual-chamber pacing system, ANP concentration significantly decreased. The baseline LVEF values were significantly higher in patients than in controls. In patients with VVI pacemakers, LVEF significantly increased, both 7 and 30 days after implantation. In patients with dual-chamber pacemakers, LVEF tended to increase 7 days after implantation and slightly decreased 30 days after implantation, however, the differences were not significant.
Conclusions: ANP level decreases following pacemaker implantation in patients with advanced a-v block which suggests an improvement of cardiac performance. Assessment of ANP may be useful in selection of pacing mode.

Abstract

Background: The effects of different modes of pacing on cardiac performance have been investigated in a few small studies, and the results are not conclusive.
Aim: To assess the effects of different modes of pacing on atrial natriuretic peptide (ANP) plasma concentration and left ventricular ejection fraction (LVEF).
Methods: The study group consisted of 55 subjects without symptomatic CHF. Forty patients were in sinus rhythm and had a-v block. Twenty of them, aged 71-90 years, mean 77.5±5.9 years, received VVI pacemaker, and the remaining 20 patients aged 49-81 years, mean 68.9±11.9 years, received DDD or VDD pacemakers. The control group consisted of 15 healthy volunteers aged 58-80 years, mean 72.6±2.8 years. Blood samples for α ANP concentration were taken before pacemaker implantation and 7 as well as 30 days after pacemaker implantation. In controls, a single α ANP measurement was performed. Transthoracic echocardiography was performed in all patients and controls at the same time-points as ANP assessment in order to calculate LVEF.
Results: Before pacemaker implantation, ANP plasma concentration was the highest in VVI patients and was significantly greater in patients than in controls. Following VVI pacemaker implantation, ANP level significantly decreased, both 7 and 30 days after implantation when compared with baseline values. Also following implantation of dual-chamber pacing system, ANP concentration significantly decreased. The baseline LVEF values were significantly higher in patients than in controls. In patients with VVI pacemakers, LVEF significantly increased, both 7 and 30 days after implantation. In patients with dual-chamber pacemakers, LVEF tended to increase 7 days after implantation and slightly decreased 30 days after implantation, however, the differences were not significant.
Conclusions: ANP level decreases following pacemaker implantation in patients with advanced a-v block which suggests an improvement of cardiac performance. Assessment of ANP may be useful in selection of pacing mode.
Get Citation

Keywords

anp - ejection fraction - permanent pacing mode

About this article
Title

Atrial natriuretic peptide for monitoring cardiovascular system performance following pacemaker implantation

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 62, No 3 (2005)

Pages

206-209

Published online

2005-12-12

Bibliographic record

Kardiol Pol 2005;62(3):206-209.

Keywords

anp - ejection fraction - permanent pacing mode

Authors

Janusz Sielski
Marianna Janion
Zenon Gawor

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl